Han.biomedical Inc. (TPEX:6999)
Taiwan · Delayed Price · Currency is TWD 31.45
-0.05 (-0.16%)
At close: May 8, 2026
Han.biomedical Market Cap
Han.biomedical has a market cap or net worth of 692.37 million as of May 8, 2026. Its market cap has decreased by -8.80% in one year.
Market Cap
692.37M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
31.45
Market Cap Chart
Since July 31, 2024, Han.biomedical's market cap has decreased from 788.04M to 692.37M, a decrease of -12.14%. That is a compound annual growth rate of -7.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 692.37M | -14.42% |
| Dec 31, 2025 | 809.05M | 20.08% |
| Dec 30, 2024 | 673.74M | -14.51% |
| Jul 31, 2024 | 788.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 17.55B |
| Elixiron Immunotherapeutics (Cayman) Limited | 9.47B |
| Uwell Biopharma | 8.20B |
| Intelligene | 7.40B |
| Obigen Pharma | 3.99B |
| BIONET Therapeutics | 2.84B |
| Pet Pharm Biotech | 2.73B |
| FullHope Biomedical | 1.12B |